Table 1 Basic clinical and laboratory characteristics of the two groups
characteristics | CI-AKI group (n = 174) | non-CI-AKI group (n = 757) | P value |
|---|---|---|---|
Clinical variables | |||
Age (years) | 65.48 ± 11.29 | 62.21 ± 11.29 | 0.001 |
Male(n, %) | 129 (74.14) | 601 (79.39) | 0.129 |
Smoking (n, %) | 48 (27.59) | 222 (29.33) | 0.648 |
Drinking (n, %) | 22 (12.64) | 105 (13.87) | 0.671 |
Hypertension (n, %) | 119 (68.39) | 474 (62.62) | 0.153 |
Diabetes mellitus(n, %) | 48 (27.59) | 188 (24.83) | 0.452 |
LVEF< 40% (n, %) | 29 (16.67) | 100 (13.21) | 0.234 |
Laboratory variables | |||
Lp(a)(mg/L) | 223.50 (110.50, 457.75) | 132.00 (71.00, 300.50) | < 0.001 |
ApoA-Ι(g/L) | 1.18 (1.02,1.37) | 1.20 (1.08,1.36) | 0.394 |
ApoB(g/L) | 0.84 (0.66,1.03) | 0.78 (0.63,0.93) | 0.002 |
ApoB/ApoA-Ι ratio | 0.71 (0.55, 0.90) | 0.64 (0.51,0.78) | 0.001 |
RBC(1012/L) | 4.45 (3.83, 4.85) | 4.47 (4.06, 4.85) | 0.275 |
Hb(g/L) | 135.00 (119.25, 147.00) | 139.00 (125.00, 150.00) | 0.010 |
HCT(%) | 41.36 (39.66,43.91) | 42.06 (39.46, 44.86) | 0.064 |
TC (mmol/L) | 4.20 (3.21, 4.99) | 4.02 (3.30, 4.75) | 0.094 |
TG (mmol/L) | 1.43 (0.96, 1.99) | 1.32 (0.91, 1.93) | 0.220 |
TP(U/L) | 65.18 ± 5.95 | 64.70 ± 5.94 | 0.345 |
ALB(U/L) | 39.71 ± 4.30 | 40.16 ± 3.94 | 0.179 |
urea (mmol/L) | 6.11 (4.93, 7.50) | 5.60 (4.56, 6.74) | 0.001 |
Baseline Cr (μmol/L) | 77.50 (65.00, 94.25) | 70.00 (60.00, 84.00) | < 0.001 |
Baseline eGFR (mL/min) | 82.68 (64.48, 97.65) | 93.60 (81.43, 103.25) | < 0.001 |
UA (μmol/L) | 387.50 (323.50, 487.25) | 375.00 (311.50, 447.00) | 0.045 |
Glu (mmol/L) | 5.92 (4.94, 7.77) | 5.71 (4.82, 7.18) | 0.228 |
HDL-C (mmol/L) | 0.93 (0.81, 1.20) | 0.98 (0.82, 1.14) | 0.712 |
LDL-C (mmol/L) | 2.41 (1.67, 3.18) | 2.29 (1.74, 2.96) | 0.237 |
sdLDL (mmol/L) | 0.84 (0.60,1.15) | 0.79 (0.57,1.11) | 0.392 |
LDL-C/HDL-C ratio | 2.41 (1.77,3.32) | 2.38 (1.74,3.04) | 0.164 |
hsCRP (mg/L) | 5.09 (1.59,18.66) | 2.28 (0.45, 8.83) | < 0.001 |
Postoperative eGFR (mL/min) | 67.72 (43.36,81.85) | 86.27 (73.53,94.44) | < 0.001 |
Postoperative Cr (μmol/L) | 102.5 (84.75,124.25) | 81.00 (69.00,96.50) | < 0.001 |
Medication(n,%) | |||
Statin | 160 (91.95) | 667 (88.11) | 0.147 |
ACEI/ARB | 117 (67.24) | 523 (69.09) | 0.636 |
β-bloker | 140 (80.46) | 583 (77.01) | 0.325 |
Calcium channel blocker | 16 (9.20) | 56 (7.40) | 0.423 |
Diuretics | 37 (21.26) | 101 (13.34) | 0.008 |
Procedural characteristic | |||
Contrast volume (mL) | 129.00 (120.00,146.25) | 130.00 (120.00,142.00) | 0.712 |
Contrast exposure time (min) | 56.00 (49.50,65.00) | 56.00 (48.00,64.00) | 0.374 |
Multivessel disease(n,%) | 77 (44.25) | 328 (43.33) | 0.825 |